Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03237195 · ClinicalTrials.gov registry record
Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection.
A clinical trial, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 139
- Enrollment target
NCT03237195: Completed study, sponsored by University of Mississippi Medical Center.
NCT03237195 is a clinical trial that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 139 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03237195 has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 139 participants
- Enrollment target
Study Summary
Most patients with cancer of the head and neck are offered surgical resection of the primary tumor. In order to determine how the tumor will eventually behave, along with the resection of the primary tumor, lymph nodes present in the neck are also dissected. Different institutes have different protocol on handling of the specimen that is received by the pathology labs after dissection of the neck. The investigators intend to analyze the protocol that they use to evaluate the neck dissection specimen.
Primary Outcome
Number of additional lymph nodes obtained with additional sampling of soft tissue
Interventions
- OTHER additional soft tissue in neck dissections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2017-12-31 |
What the finished NCT03237195 record still lists
NCT03237195 is an observational study that tracks outcomes without assigning an intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which additional soft tissue in neck dissections is the first listed.
NCT03237195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03237195 about?
NCT03237195 is a clinical study titled "Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection.". Most patients with cancer of the head and neck are offered surgical resection of the primary tumor. In order to determine how the tumor will eventually behave, along with the resection of the primary tumor, lymph nodes present in the neck are also dissected. Different institutes have different proto...
What is the current status of trial NCT03237195?
This trial is currently completed. The enrollment target is 139 participants. The study started on 2013-01-01. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT03237195?
The interventions under investigation include: additional soft tissue in neck dissections (OTHER).
Who is sponsoring clinical trial NCT03237195?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI